Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system-Reference-Cited by-同舟云学术

Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system

Published:2011-07-11 Issue:10 Volume:25 Page:3505-3518
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Rahim Ahad A.¹,Wong Andrew M. S.²,Hoefer Klemens²,Buckley Suzanne M. K.¹,Mattar Citra N.³,Cheng Seng H.⁴,Chan Jerry K. Y.³⁵,Cooper Jonathan D.²,Waddington Simon N.¹

Affiliation:

1. Gene Transfer Technology Group, Institute for Women's HealthUniversity College London London UK

2. Pediatric Storage Disorders LaboratoryInstitute of Psychiatry, King's College London London UK

3. Experimental Fetal Medicine Group, Department of Obstetrics and GynaecologyNational University of Singapore Singapore

4. Genzyme Corporation Framingham MA USA

5. Department of Reproductive MedicineKandang Kerbau Women's and Children's Hospital Singapore

Funder

Wellcome Trust

Batten Disease Family Association

Batten Disease Support and Research Association

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.11-182311

Reference45 articles.

1. Glucosylsphingosine Accumulation in Mice and Patients with Type 2 Gaucher Disease Begins Early in Gestation

2. Gaucher disease

3. Epidemiology of preterm birth and neonatal outcome

4. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94

5. Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of different promoters to improve AAV vector-mediated gene therapy for neuronopathic Gaucher disease;Human Molecular Genetics;2024-05-16

2. Role of Microglial Modulation in Therapies for Perinatal Brain Injuries Leading to Neurodevelopmental Disorders;Advances in Neurobiology;2024

3. Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups;International Journal of Molecular Sciences;2023-10-18

4. Fetal gene therapy;Journal of Inherited Metabolic Disease;2023-08-07

5. Genetic therapeutic advancements for Dravet Syndrome;Epilepsy & Behavior;2022-07